Compare Corteva Inc. Common Stock (CTVA) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corteva Inc. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Corteva Inc. Common Stock trades at $13.19 (market cap $9.17B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: Corteva Inc. Common Stock is far larger — about 4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Corteva Inc. Common Stock pays a 5.24% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| CTVA | SLS | |
|---|---|---|
Market Cap | $9.17B | $2.27B |
Volume | 35,183,471 | 4,179,659 |
Sector | Basic Materials | Health |
52-Week High | $90.51 | $15.46 |
52-Week Low | $11.92 | $1.39 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $11.68B | $2.14B |
Dividend Yield | 5.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Corteva Inc. Common Stock
Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.
Read more on CTVA →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
